These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23524956)

  • 21. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA; Wilson JA
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in Liver Health and Disease.
    Hsu SH; Ghoshal K
    Curr Pathobiol Rep; 2013 Mar; 1(1):53-62. PubMed ID: 23565350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complexities of microRNA regulation: mirandering around the rules.
    Breving K; Esquela-Kerscher A
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1316-29. PubMed ID: 19800023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Way to Infer the Regulation Relations of miRNAs on Target Genes and Critical miRNAs in Cancers.
    Xu P; Wu Q; Yu J; Rao Y; Kou Z; Fang G; Shi X; Liu W; Han H
    Front Genet; 2020; 11():278. PubMed ID: 32296462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA therapeutics: RNAi and antisense mechanisms and clinical applications.
    Chery J
    Postdoc J; 2016 Jul; 4(7):35-50. PubMed ID: 27570789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as Therapeutic Targets in Lung Disease: Prospects and Challenges.
    Sato T; Baskoro H; Rennard SI; Seyama K; Takahashi K
    Chronic Obstr Pulm Dis; 2015 Dec; 3(1):382-388. PubMed ID: 28848860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach.
    Prokopi M; Kousparou CA; Epenetos AA
    Front Oncol; 2014; 4():389. PubMed ID: 25717438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting MicroRNA Function in Respiratory Diseases: Mini-Review.
    Maltby S; Plank M; Tay HL; Collison A; Foster PS
    Front Physiol; 2016; 7():21. PubMed ID: 26869937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
    Novak J; Souček M
    Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.
    Miyazaki Y; Adachi H; Katsuno M; Minamiyama M; Jiang YM; Huang Z; Doi H; Matsumoto S; Kondo N; Iida M; Tohnai G; Tanaka F; Muramatsu S; Sobue G
    Nat Med; 2012 Jul; 18(7):1136-41. PubMed ID: 22660636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Mechanisms of MicroRNA Downregulation in Cancer.
    Williams M; Cheng YY; Blenkiron C; Reid G
    Microrna; 2017; 6(1):2-16. PubMed ID: 27928946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic microRNAs in human cancer.
    Ors-Kumoglu G; Gulce-Iz S; Biray-Avci C
    Cytotechnology; 2019 Feb; 71(1):411-425. PubMed ID: 30600466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
    Kaboli PJ; Rahmat A; Ismail P; Ling KH
    Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-143 and -145 in colon cancer.
    Akao Y; Nakagawa Y; Naoe T
    DNA Cell Biol; 2007 May; 26(5):311-20. PubMed ID: 17504027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.